Literature DB >> 15389782

Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis.

Heléne Gustavsson1, Karin Welén, Jan-Erik Damber.   

Abstract

BACKGROUND: Androgen-independent prostate cancer is today an incurable disease, but increased understanding of the mechanisms for the transition into an androgen-independent state may increase the possibilities for more efficient strategies in the future.
METHODS: An androgen-independent subline, LNCaP-19, to the androgen-dependent prostate cancer cell line LNCaP was developed in vitro under standard culture conditions. The characteristics of LNCaP-19 regarding androgen responsiveness, PSA, and VEGF secretion was studied in vitro. The growth in vivo and the microvessel density (MVD) of the tumors were studied after inoculation in nude mice.
RESULTS: LNCaP-19 grows equally well in dextran-charcoal stripped FBS (DCC-FBS) as in normal FBS, and rapidly gives rise to tumors in both intact and castrated mice, indicating a true androgen-independent growth. The PSA secretion from LNCaP-19 cells was lower than from LNCaP cells, while the VEGF level was comparable to the secretion from LNCaP cells without androgen stimulation. The MVD was increased in the LNCaP-19 tumors, and the vessels also displayed a changed morphology with exclusively small microvessels without lumen.
CONCLUSIONS: LNCaP-19 shows characteristics resembling those of androgen-independent prostate cancer. An increased MVD and changed vessel morphology in the tumor, makes it an interesting model system for studies regarding angiogenesis in the context of the acquisition of androgen independence. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389782     DOI: 10.1002/pros.20145

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

Review 1.  Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

Authors:  Alejandro S Godoy; Ivy Chung; Viviana P Montecinos; Ralph Buttyan; Candace S Johnson; Gary J Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-02       Impact factor: 4.310

Review 2.  Angiogenesis and prostate cancer: important laboratory and clinical findings.

Authors:  Michael C Cox; Matthew Permenter; William D Figg
Journal:  Curr Oncol Rep       Date:  2005-05       Impact factor: 5.075

3.  Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.

Authors:  Xiaohai Wang; Soo Ok Lee; Shujie Xia; Qi Jiang; Jie Luo; Lei Li; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2013-03-27       Impact factor: 6.261

4.  Characterization of a novel metastatic prostate cancer cell line of LNCaP origin.

Authors:  Mark A Castanares; Ben T Copeland; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Martin G Pomper; Shawn E Lupold; Catherine A Foss
Journal:  Prostate       Date:  2015-10-26       Impact factor: 4.104

5.  ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors.

Authors:  Heléne Gustavsson; Tajana Tesan; Karin Jennbacken; Kouji Kuno; Jan-Erik Damber; Karin Welén
Journal:  BMC Cancer       Date:  2010-06-14       Impact factor: 4.430

6.  Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.

Authors:  Anders Olsson; Anders Björk; Johan Vallon-Christersson; John T Isaacs; Tomas Leanderson
Journal:  Mol Cancer       Date:  2010-05-17       Impact factor: 27.401

7.  Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell.

Authors:  Alejandro Godoy; Anica Watts; Paula Sotomayor; Viviana P Montecinos; Wendy J Huss; Sergio A Onate; Gary J Smith
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

8.  Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer.

Authors:  Chen-Chin Pen; Che-Ming Liu; Cho-Chin Lin; Chia-Chen Lin; Teng-Fu Hsieh; Sajni Josson; Yun-Chi He; Leland W K Chung; Keh-Liang Lin; Shian-Ying Sung
Journal:  Chin J Physiol       Date:  2012-12-31       Impact factor: 1.764

9.  Development of the VCaP androgen-independent model of prostate cancer.

Authors:  Robert D Loberg; Lauren N St John; LaShon L Day; Chris K Neeley; Kenneth J Pienta
Journal:  Urol Oncol       Date:  2006 Mar-Apr       Impact factor: 3.498

Review 10.  Filamin A: Insights into its Exact Role in Cancers.

Authors:  Qian-Qian Shao; Tai-Ping Zhang; Wen-Jing Zhao; Zi-Wen Liu; Lei You; Li Zhou; Jun-Chao Guo; Yu-Pei Zhao
Journal:  Pathol Oncol Res       Date:  2015-09-05       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.